Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir as adjunctive therapy in generalized periodontitis
2022-501957-35-00Phase 3Authorised
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- May 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in periodontitis comparing Valaciclovir arm with Placebo arm (2 arms). Primary endpoint: Primary endpoint: pocket depth at sounding at Visit 3. Planned start May 2023; status: authorised.
02
Drugs
valaciclovir
03
Conditions
periodontitis
Beyond the preview
Go deeper on 2022-501957-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501957-35-00.